H.P. Sleeboom

Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma

David H. Henry, Luís Costa, François Goldwasser et al. · Journal of Clinical Oncology · 2011 · 1.3K citations · Full text

Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer Group

Henning T. Mouridsen, Mikhail Gershanovich, Yan Sun et al. · Journal of Clinical Oncology · 2001 · 1K citations · Full text

Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results

Robert E. Coleman, Richard de Boer, Holger Eidtmann et al. · Annals of Oncology · 2012 · 335 citations · Full text

Zoledronic Acid, Final 60-Month Results, Oncology +8

Palliative pamidronate treatment in patients with bone metastases from breast cancer.

A.Th. van Holten-Verzantvoort, Hidde M. Kroon, O. L. M. Bijvoet et al. · Journal of Clinical Oncology · 1993 · 197 citations

Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-Month Analysis of the E-ZO-FAST Trial

Antonio Llombart‐Cussac, Antonio Frassoldati, Outi Paija et al. · Clinical Breast Cancer · 2011 · 130 citations · Full text